Bond AbbVie Inc. 1.25% ( XS2055647213 ) in EUR
Issuer | AbbVie Inc. |
Market price | ![]() |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 1.25% per year ( payment 1 time a year) |
Maturity | 17/11/2031 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | / |
Total amount | / |
Next Coupon | 18/11/2025 ( In 102 days ) |
Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. This financial analysis details the bond identified by ISIN XS2055647213, an EUR-denominated debt instrument issued by AbbVie, a leading global biopharmaceutical company headquartered in the United States, widely recognized for its research-driven approach to discovering and developing advanced therapies for complex diseases. This particular security, bearing an annual interest rate of 1.25% with payments occurring once per year, is presently quoted on the market at 90.26% of its nominal value and is set to reach its maturity on November 17, 2031. |